Drug Trial Radar · NCT00528112
Levonorgestrel Contraceptive Intrauterine Systems (LCS) Pearl Index Study
Last checked: Nov 19, 2026Latest source record: Jan 25, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
2,885
Actual
Start
Aug 2007
Primary completion
Jul 2011
Study completion Jun 2013
Sponsor
- Lead sponsor
- BayerBayer (BAYRY)
- Sponsor type
- Industry
- First posted
- Sep 12, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Prevention
- Who can join
- Female only, from 18 years, up to 35 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This is a study on a new low dose levonorgestrel contraceptive intrauterine systems (LCS). The purpose of the study is to investigate which of the 2 administered doses is the lowest effective intrauterine dose of Levonorgestrel (LNG) administered via the LCS for contraception during 3 years. The study was amended: the LCS16 arm will be extended up to 5 years
Conditions
- Contraception
Interventions
LCS12Drug
Intrauterine system (IUS) with Levonorgestrel, in vitro releasing rate 12 microg/24 h
LCS16Drug
Intrauterine system (IUS) with Levonorgestrel, in vitro releasing rate 16 microg/24 h
Primary outcomes
What the sponsor says the trial is designed to measure.
- Pearl Index up to 3 YearsTime frame: Up to 3 years
- Pearl Index for LCS16 up to 5 YearsTime frame: Up to 5 years
Locations
136 sites in 11 countries. Site status is shown where the registry gives one.
Site not named
Mobile, Alabama
Site not named
Glendale, Arizona
Site not named
Phoenix, Arizona
Site not named
Tucson, Arizona
Site not named
Carmichael, California
Site not named
Pacific Palisades, California
Site not named
San Diego, California
Site not named
San Diego, California
Site not named
San Diego, California
Site not named
San Diego, California
Site not named
Torrance, California
Site not named
Denver, Colorado
Site not named
Littleton, Colorado
Site not named
Boyton Beach, Florida
Site not named
Jacksonville, Florida
Site not named
Miami, Florida
Site not named
West Palm Beach, Florida
Site not named
Atlanta, Georgia
Site not named
Decatur, Georgia
Site not named
Boise, Idaho
Site not named
Idaho Falls, Idaho
Site not named
Chicago, Illinois
Site not named
Evansville, Indiana
Site not named
South Bend, Indiana
Site not named
Marrero, Louisiana
Site not named
Boston, Massachusetts
Site not named
Kalamazoo, Michigan
Site not named
Chaska, Minnesota
Site not named
Chesterfield, Missouri
Site not named
Lincoln, Nebraska
Site not named
Las Vegas, Nevada
Site not named
Las Vegas, Nevada
Site not named
Las Vegas, Nevada
Site not named
Moorestown, New Jersey
Site not named
New Brunswick, New Jersey
Site not named
Albuquerque, New Mexico
Site not named
New York, New York
Site not named
New Bern, North Carolina
Site not named
Winston-Salem, North Carolina
Site not named
Cincinnati, Ohio
Showing 40 of 136 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.